NCT02302833
- Conditions
- Locally Advanced Paraganglioma, Metastatic Adrenal Gland Pheochromocytoma, Metastatic Paraganglioma, +11 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Clinical trial condition
Metastatic Paraganglioma
Explore clinical trials studying Metastatic Paraganglioma. Study availability and eligibility vary by location and protocol.
3 public trials
0 recruiting studies
Metastatic Paraganglioma trial results
Active, Not Recruiting
Pembrolizumab in Treating Patients With Rare Tumors That Cannot Be Removed by Surgery or Are Metastatic
NCT02721732
- Conditions
- Adenocarcinoma, Adrenal Cortex Diseases, Adrenal Cortex Neoplasms, +59 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Active, Not Recruiting
Testing the Addition of an Anticancer Drug, Olaparib, to the Usual Chemotherapy (Temozolomide) for Advanced Neuroendocrine Cancer
NCT04394858
- Conditions
- Advanced Adrenal Gland Pheochromocytoma, Advanced Paraganglioma, Metastatic Adrenal Gland Pheochromocytoma, +13 more
- Locations
-
- Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
- Anchorage Radiation Therapy Center Anchorage, Alaska, United States
- Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
- Alaska Oncology and Hematology LLC Anchorage, Alaska, United States